The present invention relates to crystalline pridopidine free base and a process for its preparation. The invention also relates to a pharmaceutical composition comprising crystalline pridopidine free base and one or more pharmaceutically acceptable ingredients and to the use of said pharmaceutical composition as a medicament, in particular for the treatment of Huntingtons disease.